BioniCare is a non-invasive, non-drug treatment option for osteoarthritis (OA) of the knee and rheumatoid arthritis (RA) of the hand. The BioniCare system provides an electrical signal that stimulates the joint tissue to reduce the pain and symptoms of arthritis and helps maintain the health of the knee joint and improve the function of the hand.
BlastX™ is a breakthrough antimicrobial wound gel powered by Next Science’s patented, non-toxic, biofilm-disruption Xbio™ technology. It deconstructs the bacterial biofilm EPS matrix, destroys bacteria within the gel and defends from recolonization while maintaining a moist wound environment.
GTI uses state-of-the-art instrumentation to provide advanced pharmacogenetic testing, also called DNA Drug Sensitivity Testing. Pharmacogenetics is the study of how genes affect a person’s response to drugs. This relatively new field combines pharmacology (the science of drugs) and genetics (the study of genes and their functions) to develop effective, safe medication dosages specific to an individual’s DNA makeup.